Clinical Trial

The Effect of Intraoperative Binaural Beats on Remimazolam Dose Required for Maintenance of General Anesthesia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective randomized controlled trial evaluates whether intraoperative binaural beats reduce the remimazolam dose required for general anesthesia in 88 adults undergoing breast surgery. Patients are assigned to binaural beats or silent earphones, and the primary outcome is total intraoperative remimazolam consumption.
Trial Details
NCT Number NCT07311642
Lead Sponsor Seoul National University Hospital
Conditions Breast Reconstruction
Enrollment 88 participants
Start Date 2026-01-31
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-31